- Home
- REI vs CATX Comparison
REI vs CATX Comparison
Compare REI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REI | CATX |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.0M | 355.0M |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | REI | CATX |
|---|---|---|
| Price | $1.51 | $2.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | ★ 3.0M | 995.8K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,178,072.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.17 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.83 | $1.96 |
| 52 Week High | $2.00 | $6.16 |
Technical Indicators
Market Signals| Indicator | REI | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 65.01 | 42.11 |
| Support Level | $1.23 | $2.82 |
| Resistance Level | $1.64 | $3.56 |
| Average True Range (ATR) | 0.06 | 0.17 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 75.00 | 0.84 |
Price Performance
Historical ComparisonAbout REI Ring Energy Inc.
Ring Energy Inc is an independent oil and natural gas exploration and production company based in the United States. It is engaged in oil and natural gas development, production, acquisition, and exploration activities, currently focused on the Permian Basin of Texas. The company's drilling operations target the oil and liquids-rich producing formations in the Northwest Shelf and the Central Basin Platform, in the Permian Basin in Texas.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.